EXA
Desconocido
OCTCHIP: Ophthalmic OCT on a Chip
EXALOS AG
participó en un
H2020:
H2020-ICT-2015
Silicon photonics is expected to leverage-off many of the advances made in CMOS electronics. International R&D efforts in this field have so...
2015-10-26 - 2021-03-31 | Financiado
2015-10-26 - 2021-03-31 | Financiado
BETACURE: Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta cell pathology
EXALOS AG
participó en un
FP7:
Background:
Hyperinsulinaemic hypoglycaemia (HH) is a potentially lethal disease caused by over functioning beta cells derived from the panc...
Financiado
Financiado
FAMOS: Functional anatomical molecular optical screening
EXALOS AG
participó en un
FP7:
Biophotonics offers low-cost, non-invasive, accurate, rapid alternatives to conventional diagnostic methods and has the potential to address...
Financiado
Financiado
BIOPSYPEN: OPTICAL BIOPSY PEN A COMPACT AND LOW COST DIAGNOSTIC TOOL FOR DERMATOLOGY BASED ON HIGH PERFORMING...
EXALOS AG
participó en un
FP7:
Optical coherence tomography (OCT) is an emerging optical diagnosis that enables in vivo tomographic visualization for non-invasive optical...
Financiado
Financiado
* No se disponen de datos de la empresa actual.